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ABSTRACT 26 
Introduction: Exercise performed with blood flow restriction simultaneously enhances 27 
the acute responses to both myogenic and mitochondrial pathways with roles in training 28 
adaptation. Methods: We investigated isoform-specific gene expression of the 29 
peroxisome proliferator-activated receptor gamma (PPARG) coactivator 1 and selected 30 
target genes and proteins regulating skeletal muscle training adaptation. Methods: 9 31 
healthy, untrained males participated of a randomized counter-balanced, cross-over 32 
design in which each subject completed a bout of low-intensity endurance exercise 33 
performed with blood flow restriction (15 min cycling at 40% of VO2peak, BFR-EE), 34 
endurance exercise (30 min cycling at 70% of VO2peak, EE) or resistance exercise (4 x 35 
10 repetitions of leg press at 70% of 1-repetition maximum, RE), followed by one 36 
biopsy (vastus lateralis) 3 hr after each boat. All exercise sessions were separate by one 37 
week. As control a single resting muscle biopsy was obtained two weeks before the first 38 
exercise trial (rest). Results: Total PGC-1α mRNA abundance, along with all four 39 
isoforms, increased above rest with EE only (P<0.05) being higher than BFR-EE 40 
(P<0.05).  PGC-1α1, 2 and 4 were higher after EE compared to RE (P<0.05). EE also 41 
increased VEGF, Hif-1α and MuRF-1 mRNA abundance above rest (P<0.05) while 42 
COXIV mRNA expression increased with EE compared to BFR-EE (P<0.05). 43 
Conclusion: The attenuated expression of all four PGC-1α isoforms when endurance 44 
exercise is performed with blood flow restriction suggests this type of exercise provides 45 
an insufficient stimulus to activate the signaling pathways governing mitochondrial and 46 
angiogenesis responses observed with moderate- to high intensity endurance exercise.  47 
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 52 
Introduction 53 
 Skeletal muscle is a highly malleable tissue that can alter its phenotype 54 
according to the contractile stimulus imposed (39). For instance, moderate-intensity 55 
(i.e., <65% of peak oxygen uptake [VO2peak]) endurance exercise training enhances 56 
whole-body V̇O2peak (3, 12), increases the maximal activities of oxidative enzymes, and 57 
shifts patterns of substrate selection from carbohydrate- to fat-based fuels (18). In 58 
contrast, strenuous (80% of one repetition maximum [1-RM]) resistance exercise has 59 
little or no effects on whole-body VO2peak and oxidative enzyme profiles (11) but 60 
increases myofibrillar protein accretion and muscle cross-sectional area (CSA) (27). 61 
 62 
While resistance and endurance exercise could be considered at opposite ends of 63 
the ‘adaptation continuum’ by virtue of their divergent biochemical and morphological 64 
phenotypes, blood flow restriction during low-intensity endurance exercise (BFR-EE) 65 
improves both VO2peak, muscle strength and CSA (1, 2). Abe and co-workers (1) 66 
reported significant increased, although quite small relative to traditional endurance and 67 
resistance exercise, isometric muscle strength, muscle CSA and VO2peak following 8 68 
weeks (24 training sessions) of low-intensity cycle exercise (15 min at 40% VO2peak) 69 
performed with BFR-EE compared to same exercise undertaken without BFR. These 70 
findings suggest the local hypoxia induced by BFR induces an additive ‘metabolic 71 
stressor’ that perturbs cellular homeostasis (17) and concomitantly enhances both 72 
anabolic and oxidative adaptations. 73 
 74 
The cellular mechanisms mediating adaptation responses to exercise are 75 
complex involving the cross talk of several intracellular signaling systems that 76 
ultimately form the basis for specific phenotypic responses with divergent contractile 77 
modes (17). The transcriptional co-activator Peroxisome proliferator-activated receptor 78 
gamma (PPARG) coactivator 1 alpha (PGC-1α) is a ‘master regulator’ of many 79 
endurance exercise-induced adaptations by virtue of its central role in promoting 80 
mitochondrial biogenesis, angiogenesis, and inflammatory proteins (20). Transcription 81 
of the PGC-1α gene has been shown to be under the control of several promoter regions 82 
with activation of the alternative PGC-1α1 promoter resulting in the transcription of 83 
three additional isoforms: PGC-1α2, -α3 and-α4. Ruas and colleagues (30) recently 84 
demonstrated a preferential increase in the PGC1-α4 isoform following resistance 85 
exercise in human skeletal muscle. However, little is known about the regulation of the 86 
α2 and α3 isoforms and, to date, no studies have investigated the expression of all four 87 
PGC-1α isoforms to diverse contractile stimuli such as resistance and endurance 88 
exercise in humans. Accordingly, the aim of the present study was to compare the acute 89 
molecular responses mediated by the different PGC-1α isoforms following low intensity 90 
endurance exercise (BFR-EE), resistance exercise (RE) and moderate endurance 91 
exercise (EE). As BFR-EE can promote both endurance capacity and muscle 92 
hypertrophy responses, we hypothesised EE and RE would selectively increase the 93 
expression of the PGC-1α1 and α4 isoforms, respectively. In contrast, we hypothesized 94 
that BFR-EE would upregulate a molecular signature involving the increase of both 95 
isoforms and their respective anabolic and mitochondrial gene targets. 96 
 97 
METHODS 98 
Subjects  99 
Nine untrained, healthy male subjects [age 22.4 ± 3.0 yr, body mass (BM) 73.5 ± 100 
9.7 kg, height 1.79 ± 0.05 m, maximal oxygen uptake test (VO2peak) 36.8 ± 4.8 mLlkg-101 
1
·min-1, leg press one repetition maximum (1-RM) 266 ± 66 kg; values are mean ± SD] 102 
voluntarily participated in this study. The experimental procedures and possible risks 103 
associated with the study were explained to all subjects, who provided written informed 104 
consent before participation. The study was approved by the local University’s Ethics 105 
Committee and conducted in conformity with the policy statement regarding the use of 106 
human subjects according to the latest revision of the Declaration of Helsinki. 107 
 108 
Experimental Design  109 
The study employed a randomized counter-balanced, cross-over design in which 110 
each subject completed a bout of either resistance exercise (RE), endurance cycling 111 
exercise (EE) or low-intensity cycling exercise combined with blood flow restriction 112 
(BFR-EE). Two weeks prior to the first exercise session, a resting muscle biopsy was 113 
obtained before participants underwent VO2peak and one-repetition maximum (1-RM) 114 
testing, and exercise familiarization. Exercise trials were separated by a one-week 115 
recovery period during which time subjects maintained their habitual diet and physical 116 
activity patterns.  117 
 118 
Preliminary Testing 119 
VO2peak. Participants performed a maximum graded exercise test on a cycle 120 
ergometer with electromagnetic braking (Quinton modelo: Corival 400, Lode BV, 121 
Groningen, Netherlands). After resting on the bike for 5 min, participants commenced 122 
the incremental test protocol. Briefly, subjects commenced cycling at an initial load of 123 
50 W for 1 min and the workload was increased by 15 W/min until a workload of 200 124 
W was reached, after which further increases were 10 W/min increments. The test 125 
continued until voluntary exhaustion, defined by two of the three following criteria: 126 
VO2peak plateau (< 2.1 mL.kg-1.min-1 of variation), > 1.10 respiratory exchange ratio, 127 
and/or heart rate higher than 90% of maximum estimated from age (19). Gas exchange 128 
data were collected continuously using an automated breath-by-breath metabolic system 129 
(CPX, Medical Graphics, St. Paul, Minnesota, USA) and the highest oxygen 130 
consumption value was defined as the peak oxygen consumption (VO2peak) over any 30 131 
sec period.  132 
 133 
Maximal Strength  134 
The one-repetition maximum (1-RM) test was performed on a leg press machine 135 
(45º leg press, G3-PL70; Matrix, São Paulo, Brazil) as previously described (8). Briefly, 136 
participants performed a 5 min warm-up on a cycle ergometer riding at 25 W. 137 
Participants then undertook 1 x 10 repetitions at 50% of their estimated 1-RM, followed 138 
by 1 x 3 repetitions at 70% of the estimated 1-RM with 1-min rest between sets. 139 
Participants then performed a series of single repetitions until the maximum load (1-140 
RM) lifted was established with fully eccentric-concentric movement with 90º range of 141 
motion. Repetitions were separated by a 3-min recovery and were used to establish the 142 
maximum load/weight that could be moved through the full range of motion once, but 143 
not a second time. 144 
 145 
Diet/Exercise Control 146 
Before each experimental trial (described subsequently), subjects were instructed 147 
to refrain from exercise training and vigorous physical activity, and alcohol and caffeine 148 
consumption for a minimum of 48 h. Subjects were provided with standardized 149 
prepacked meals that consisted of 3 g carbohydrate/kg body mass (BM), 0.5 g 150 
protein/kg BM, and 0.3 g fat/kg body mass consumed as the final caloric intake the 151 
evening before reporting for an experimental trial. 152 
 153 
Experimental Testing Sessions  154 
On the morning of an experimental trial, subjects reported to the laboratory after a ~10-155 
h overnight fast. After resting in the supine position for ~15 min and under local 156 
anaesthesia (2–3 mL of 1% Xylocaine), a resting biopsy was obtained from the vastus 157 
lateralis using a 5-mm Bergstrom needle modified with suction (7). Approximately 100 158 
mg of muscle was removed, dissected free from blood and connective tissue and snap 159 
frozen in liquid nitrogen before being stored at – 80°C until subsequent analyses. Due to 160 
ethical constraints regarding the total number of muscle biopsies allowed, this single 161 
resting biopsy was used as a basal control for all subsequent exercise trials. Two weeks 162 
later participants returned to the laboratory having (after the same pre-trial diet and 163 
exercise control) to undertake the first of three randomly assigned exercise sessions 164 
(described below). Each exercise trial was separated by a one week wash out. Following 165 
the completion of each exercise session, subjects rested for 180 min after which time a 166 
muscle biopsy was obtained. Subsequent incisions were performed 3 cm proximal to 167 
each other. Blood samples were collected before each exercise session and immediately, 168 
1, 2 hr and 3 hr post exercise. Blood samples were immediately placed in microtubes 169 
containing 1% sodium fluoride and then centrifuged at 3000 rpm for 5 min to separate 170 
the plasma before being aliquoted and frozen in liquid nitrogen and stored at -80°C. 171 
 172 
Resistance Exercise (RE) 173 
After a standardized warm-up on a cycle ergometer consisting of 5 min light 174 
cycling at 25 W, subjects performed 4 sets of 10 repetitions leg press exercise (45° leg 175 
press machine; G3-PL70; Matrix) at 70% of 1-RM. Each set was separated by a 1 min 176 
recovery period during which time subjects remained seated on the leg press machine. 177 
Complete concentric/eccentric movements were performed with 90° of range of motion 178 
and strong verbal encouragement was provided during each set. 179 
 180 
Endurance Exercise (EE) 181 
Following a standardized warm up (described previously), subjects performed 182 
30 min of continuous cycling at a power output that elicited ~at 70% of individual 183 
VO2peak.  Subjects were fan-cooled and provided visual feedback for pedal frequency, 184 
power output, and elapsed time were provided to subjects. 185 
 186 
Low Intensity Blood Flow Restriction (BFR-EE) 187 
Subjects performed 15 min continuous cycling with a cuff strapped over the 188 
thigh at a power output that elicited at 40% of VO2peak, as previously reported (1). An 189 
18-cm wide cuff was placed on the proximal portion of the thigh (inguinal fold region) 190 
over the tibial artery (38) and once in position, was inflated until an absence of auditory 191 
blood pulse detected through auscultation with a vascular Doppler probe (DV-600; 192 
Marted, São Paulo, Brazil). Pressure was then slowly released until the first arterial 193 
pulse was detected which was considered the systolic pressure at the tibial artery. Cuff 194 
pressure was set at 80% of the maximum tibial arterial pressure and the cuff was 195 
inflated through-out the entire exercise session.  196 
 197 
Analytical Procedures 198 
Blood Lactate  199 
Plasma lactate concentration was measured on a spectrophotometer (ELx800, 200 
Biotek, Winooski, USA) using a commercial kit (Biotecnica, Varginha, Brazil) 201 
according to the manufacturer’s protocol. 202 
 203 
RNA Extraction and Quantification 204 
 Approximately 20 mg of skeletal muscle was homogenized in TRIzol with 205 
chloroform added to form an aqueous RNA phase. This RNA phase was then 206 
precipitated by mixing with ice-cold isopropanol alcohol and the resulting pellet was 207 
washed and re-suspended in 40 µl of RNase-free water. Extracted RNA was quantified 208 
using a NanoDrop 1000 spectrophotometer (Nanodrop Technologies, Wilmington, 209 
USA) by measuring absorbance at 260 nm and 280 nm.  210 
 211 
Reverse Transcription  212 
First-strand complementary DNA (cDNA) synthesis was performed using 213 
commercially available TaqMan Reverse Transcription Reagents (Invitrogen, 214 
Melbourne, Australia) in a final reaction volume of 20 µL. All RNA and negative 215 
control samples were reverse transcribed to cDNA in a single run from the same reverse 216 
transcription master mix. Serial dilutions of a template human skeletal muscle RNA 217 
(AMBION; Cat No AM7982) was included to ensure efficiency of reverse transcription 218 
and for calculation of a standard curve for real-time quantitative polymerase chain 219 
reaction (RT-PCR). 220 
 221 
Real-Time PCR 222 
Quantification (in duplicate) of mRNA was performed using a CFX96 Touch™ 223 
Real-Time PCR Detection System (Bio Rad, California, USA). Taqman-FAM-labelled 224 
primer/probes for MuRF-1 (Cat No. Hs00822397_m1), COXIV (Cat No. 225 
Hs00971639_m1), IL-6 (Cat No. Hs00985639_m1), PGC-1α (Cat No. 226 
Hs01016719_m1), HIF-1α (Cat No. Hs00153153_m1), Myostatin (Hs00976237_m1), 227 
IGF-1 (Hs01547656_m1) and VEGF (Cat No. Hs00900055_m1) were used in a final 228 
reaction  volume of 20 µL. PCR treatments were 2 min at 50 ºC for UNG activation, 10 229 
min at 95 ºC then 40 cycles of 95 ºC for 15 s and 60 ºC for 60s. Glyceraldehyde-3-230 
phosphate dehydrogenase (GAPDH) (Cat No Hs02758991_g1) was used as a 231 
housekeeping gene and was stably expressed between exercise interventions (data not 232 
shown). The relative amounts of mRNAs were calculated using the relative 233 
quantification (∆∆CT) method (22). 234 
 235 
Quantification of PGC-1α isoforms 236 
RNA was extracted from a separate piece of snap frozen muscle (~20 mg) using TRIzol 237 
(Invitrogen) and purified using QIAGEN RNeasy mini-columns. Reverse transcription 238 
was performed using a High Capacity cDNA Reverse Transcription kit (Applied Bio-239 
systems). Real-Time Quantitative PCR was carried out in a SYBR Green ER PCR 240 
Master Mix (Invitrogen)/ 384-well format using an ABI PRISM 7900HT (Applied 241 
Biosystems). Relative mRNA levels were calculated using the comparative CT method 242 
and normalized to cyclophilin mRNA. Primer sequences are as follows: Cyclophilin 243 
(forward: GGAGATGGCACAGGAGGAA; reverse: GCCCGTAGTGC TTCAGTTT), 244 
PGC1α1 (forward: ATG GAG TGA CAT CGA GTG TGC T; reverse: GAG TCC ACC 245 
CAG AAA GCT GT), PGC1α2 (forward: AGT CCA CCC AGA AAG CTG TCT; 246 
reverse: ATG AAT GAC ACA CAT GTT GGG), PGC1α3 (forward: CTG CAC CTA 247 
GGA GGC TTT ATG C; reverse: CAA TCC ACC CAG AAA GCT GTC T), and 248 
PGC1α4 (forward: TCA CAC CAA ACC CAC AGA GA; reverse: CTG GAA GAT 249 
ATG GCA CAT). 250 
 251 
Western Blots 252 
Approximately 30 mg of muscle was homogenized in buffer containing 50 mM 253 
Tris·HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 50 mM 254 
NaF, 5 mM sodium pyrophosphate, 1 mM DTT, 10% μg/ml trypsin inhibitor, 2 μg/ml 255 
aprotinin, 1mM benzamidine, and 1 mM PMSF. After determination of protein 256 
concentration (Pierce, Rockford, IL), lysate was resuspended in Laemmli sample buffer. 257 
Lysate was then re-suspended in Laemmli sample buffer with 40 µg of protein loaded 258 
onto 4–20% Mini-PROTEAN TGX Stain-Free™ Gels (Bio Rad, California, USA). Post 259 
electrophoresis gels were activated according to the manufacturer’s details (Chemidoc, 260 
Bio-Rad, Gladesville, Australia) and then transferred to polyvinylidine fluoride (PVDF) 261 
membranes. After transfer, a Stain-Free image of the PVDF membranes for total protein 262 
normalization was obtained before membranes were rinsed briefly in distilled water and 263 
blocked with 5% non-fat milk, washed with 10 mM of Tris–HCl, 100 mM of NaCl, and 264 
0.02% Tween 20, and incubated with primary antibody (1:1000) overnight at 4 °C. 265 
Membranes were incubated with secondary antibody (1:2,000), and proteins were 266 
detected via chemiluminescence (Amersham Biosciences, Buckinghamshire, UK; 267 
Pierce Biotechnology, Rockford, IL) and quantified by densitometry. All sample time 268 
points for each subject were run on the same gel. Polyclonal anti-phospho-mTORSer2448 269 
(no. 2971), -p70 S6KThr389 (no. 9206), - adenosine monophosphate kinase (AMPK)Thr172 270 
(no. 2531), eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) 4E-271 
BP1Thr37/46 (no. 9459), eEF2 eukaryotic translation elongation factor 2 (eEF2) eEF2Thr56 272 
(no. 2331) and p53Ser15 (no. 9284) were purchased from Cell Signaling Technology 273 
(Danvers, MA, USA). Volume density of each target protein band was normalized to 274 
the total protein loaded into each lane using stain-free technology (15) with data 275 
expressed in arbitrary units. 276 
 277 
Statistical analysis  278 
Statistical analysis was performed using SAS version 9.3 for Windows (SAS 279 
Institute Inc., Cary, NC, USA). Data normality and variance equality were assessed 280 
through the Shapiro-Wilk and Levene tests. One-way ANOVA with repeated measures 281 
(factor: condition) was performed for gene and protein expression analyses. A mixed 282 
model ANOVA, assuming group and time as fixed factors and subjects as a random 283 
factor, was performed for blood lactate data. Tukey post hoc analysis was used for 284 
multiple comparison purposes when significant F-values were found. The significance 285 
level was set at P ≤ 0.05. Data are presented as Mean ± Standard Deviation (SD). 286 
 287 
Results 288 
mRNA expression 289 
Total PGC1-α and isoforms 290 
Total PGC-1α mRNA (Figure 1A) increased with EE above rest (P<0.0001), RE 291 
(P=0.0013) and BFR-EE (P>0.0001). There was a significant increase in PGC-1α1 292 
mRNA with EE above rest (P=0.0450), RE (P=0.0069) and BFR-EE (P=0.0349) 293 
(Figure 1B). There was also a significant increase in PGC-1α2 mRNA (Figure 1C) with 294 
EE above rest (P<0.0001), RE (P=0.0003) and BFR-EE (P<0.0001). PGC-1α3 mRNA 295 
(Figure 1D) increased with EE above rest (P=0.0389). There was also increases PGC-296 
1α4 mRNA (Figure 1E) with EE above rest (P=0.0035), RE (P=0.0469) and BFR-EE 297 
(P=0.0140). 298 
 299 
**Figure 1 here** 300 
 301 
VEGF, COXIV, HIF-1a 302 
There was a significant increase in VEGF mRNA (Figure 2A) with EE above 303 
rest (P=0.0180) and RE (P=0.0069). COXIV mRNA expression increased with EE 304 
above BFR-EE (P=0.0550) (Figure 2B). There was a significant increase in HIF-1a 305 
abundance with EE above Rest (P= 0.0530) (Figure 2C). 306 
 307 
**Figure 2 here** 308 
 309 
IL-6 – IGF-1 - Myostatin - MurRF1  310 
IL-6, IGF-1 and Myostatin mRNA expression were unchanged post-exercise 311 
(Figure 3 A, B, C).  There was a post-exercise increase in MuRF1 mRNA abundance 312 
with  EE above Rest (P=0.0003), RE (P=0.0256) and BFR-EE (P=0.0007) (Figure 3D). 313 
 314 
**Figure 3 here** 315 
 316 
Cell Signaling 317 
mTOR -p70S6K -4E-BP1 -eEF2  318 
 There were no changes in mTORSer2448, p70S6KThr389, 4E-BP1Thr37/46or eEF2Thr56 319 
phosphorylation post-exercise or between exercise groups (Figure 4). 320 
 321 
**Figure 4 here** 322 
 323 
AMPK -p53 324 
AMPKThr156and p53Ser15 phosphorylation were unchanged post-exercise (Figure 325 
5). 326 
 327 
**Figure 5 here** 328 
 329 
Plasma lactate concentration 330 
 Lactate concentration increased above rest immediately post-exercise for all 331 
interventions (P<.0001 for all comparisons; Table 1). Lactate concentration remained 332 
elevated at 1 h, 2 h and 3 h post-exercise for EE and RE, and 1 h and 2 h for BFR-EE 333 
(P<.0001 for all comparisons).  334 
 335 
**Table 1 here** 336 
 337 
Discussion 338 
It has been shown that, although quite small relative to traditional endurance and 339 
resistance exercise, Low intensity (<50% of VO2peak) endurance training with blood 340 
flow restriction concomitantly promote isometric muscle strength, muscle CSA and 341 
VO2peak (1, 2) and , while the underlying molecular mechanisms mediating these 342 
responses remain largely undefined. For the first time we report that low intensity 343 
endurance cycling exercise performed with blood flow restriction failed to increase 344 
PGC-1α expression to that commonly observed with ‘conventional’ endurance exercise. 345 
Moreover, we show isoform-specific post-exercise increases in the α4 isoform along 346 
with Hif-1α and VEGF mRNA expression following higher intensity endurance 347 
exercise without blood flow restriction. Taken collectively, our novel findings suggest 348 
that endurance exercise undertaken with blood flow restriction is unable to provoke the 349 
perturbations to cellular homeostasis necessary to induce activation of the cell signaling 350 
events regulating mitochondrial biogenesis and angiogenesis that take place with higher 351 
intensity endurance exercise without blood flow restriction. 352 
 353 
A growing body of evidence suggests that exercise undertaken with blood flow 354 
restriction can enhance exercise adaptation. A recent meta-analysis reported both low 355 
load/intensity resistance (20–30% 1 RM) and aerobic walking exercise performed with 356 
blood flow restriction can induce increases in muscle strength and hypertrophy, 357 
although with smaller gains compared to high intensity resistance exercise alone (34). 358 
However, little is known about the molecular mechanisms mediating these responses 359 
when low intensity endurance exercise is undertaken with blood flow restriction. As 360 
such, we compared the expression of key gene and protein targets implicated in a range 361 
of exercise adaptation responses such as hypertrophy, mitochondrial biogenesis, muscle 362 
proteolysis, substrate metabolism and angiogenesis between BFR-EE, and conventional 363 
bouts of RE and EE. We particularly focused on the four different full-length PGC-1α 364 
isoforms putatively implicated in anabolic and mitochondrial-related adaptation 365 
responses.  366 
 367 
In agreement with previous studies (5, 21, 26), we observed significant increases in total 368 
PGC-1α mRNA following continuous endurance exercise performed at 70% of VO2peak. 369 
This increase in PGC-1α mRNA was concomitant with greater abundance of VEGF, a 370 
target of PGC-1α (36). However, in contrast to our original hypothesis, this response 371 
was absent following a bout of low-intensity endurance exercise (40% VO2peak) 372 
performed with blood flow restriction. In an attempt to identify possible mechanisms 373 
responsible for this attenuated PGC-1α response, we investigated IL-6 expression to 374 
determine whether an increase in the muscular inflammatory program was implicated in 375 
the blunted response. This hypothesis was based on previous data showing an inverse 376 
relationship between skeletal muscle PGC-1α and IL-6 expression (16). However, IL-6 377 
mRNA expression post-exercise was unchanged in all exercise groups suggesting any 378 
acute increase in muscle inflammation caused by BFR-EE was not responsible for the 379 
reduced PGC-1α1 expression observed. We also investigated other cellular markers 380 
implicated in exercise adaptation responses that can regulate PGC-1α expression. 381 
AMPK is an intracellular ‘fuel gauge’ that can phosphorylate PGC-1α and increase its 382 
transcriptional activity (35) while the apoptogenic protein p53 has emerged as another 383 
signaling regulator of skeletal muscle exercise-induced mitochondrial biogenesis and 384 
substrate metabolism that can translocate to the nucleus upon activation and induce 385 
PGC-1α expression (4). Phosphorylation of either of these protein targets was unaltered 386 
post-exercise suggesting other molecular markers and/or physiological mechanisms 387 
may be responsible for the upregulation of PGC-1α with high intensity endurance 388 
exercise. One plausible explanation for these discrepant findings may be the level of 389 
glycogen utilization between exercise sessions in our untrained subjects. We (10) and 390 
others (6, 29) have shown greater post-exercise PGC-1α expression with low- compared 391 
to normal or high glycogen concentration and although we did not measure muscle 392 
glycogen use in the current study due to limited muscle tissue availability, the longer 393 
duration and higher intensity exercise bout is likely to have induced greater glycogen 394 
depletion compared to the endurance exercise session performed with blood flow 395 
restriction.  396 
 397 
Another possible explanation for the discrepancy in PGC-1α1 expression between the 398 
two endurance-based exercise bouts is the large differences in estimated energy 399 
expenditure. Exercise energy expenditure after BFR-EE was ~4 fold less compared to 400 
the EE protocol with total energy expenditure positively associated with PGC-1α 401 
expression (r=0.73, P=0.039). Increased PGC-1α mRNA expression has been observed 402 
after 30 min running compared to bouts of 20 and 10 min (36). Thus, total exercise-403 
induced energy expenditure may be an overriding determinant of PGC-1α expression 404 
responses post-exercise.  405 
 406 
Low intensity endurance exercise with BFR was also unable to induce the expression of 407 
PGC-1α4 compared to higher intensity endurance exercise without blood flow 408 
restriction. The PGC-1α4 isoform has been proposed to promote muscle hypertrophy by 409 
inducing IGF-1 expression and reducing the expression of myostatin, a negative 410 
regulator of muscle growth (30). The increase in PGC-1α4 mRNA expression with EE 411 
was mirrored by a small, non-significant, increase and decrease in IGF1 and myostatin 412 
expression, respectively. Other studies have also observed increases in PGC-1α4 413 
expression with endurance exercise (33, 40) suggesting this isoform can be regulated 414 
with acute exercise independent of contractile mode. 415 
 416 
Increased PGC-1α4 and VEGF expression has also been reported in primary myotubes 417 
treated under hypoxic conditions suggesting low oxygen conditions to be favorable for 418 
the activation of this isoform (37). In the current study, the transcription factor Hif-1α, a 419 
key regulator of angiogenesis in situations of hypoxia (32), was unchanged following 420 
BFR-EE, while RE and EE induced 2-fold higher post-exercise changes in lactate 421 
compared to BFR-EE. While it is possible a greater metabolic and hypoxic stimulus 422 
may be required to increase PGC-1α4 signaling, others have reported unchanged blood 423 
lactate following aerobic-based exercise with blood flow restriction (23). Moreover, the 424 
same occlusion protocol (15 min cycle at 40% VO2peak) has been shown to improve 425 
muscle volume and VO2peak, during a chronic training intervention (1). Thus, it is 426 
possible chronic exposure to this occlusion stimulus may be required to elicit increases 427 
in PGC-1α4 expression. As this is the first study to investigate changes in Hif-1α 428 
following endurance cycling exercise with BFR it is difficult to compare our results to 429 
those of previous investigations incorporating resistance exercise and BFR. However, 430 
we speculate that when performed with blood flow restriction, the lower contractile 431 
intensity associated with ‘conventional’ endurance compared to resistance (or sprint) 432 
exercise, provides adequate blood flow to the exercising musculature and adjoining 433 
capillary beds in order to prevent tissue de-oxygenation. Further studies comparing 434 
different low intensity endurance exercise protocols with resistance exercise that 435 
incorporate blood flow restriction are required to corroborate this hypothesis. 436 
 437 
Another novel finding from the current study was the post-exercise increases in the 438 
PGC-1α2 and 3 isoforms. Similar to the α1 and α4 isoforms, both PGC-1α2 and α3 439 
increased above rest with higher intensity endurance exercise and were significantly 440 
elevated compared to resistance exercise. Both isoforms are expressed in skeletal 441 
muscle and brown adipose tissue although little is known about the regulatory targets of 442 
these isoforms and their capacity to mediate exercise adaptation responses. Accordingly 443 
with Ruas et al (2012) the functions of PGC-1α2 and α3 remain under investigation, 444 
however, based on the elevated response following endurance compared to resistance 445 
exercise, we propose these isoforms to mediate physiological processes related to 446 
mitochondrial biogenesis and substrate metabolism.    447 
 448 
Considering low load endurance exercise with BFR can increase muscle strength and 449 
hypertrophy (34), we also investigated markers of translation initiation, elongation and 450 
muscle proteolysis. Previous studies have reported increases in mTOR and p70S6K 451 
phosphorylation that have formed the basis for enhanced rates of muscle protein 452 
synthesis following resistance exercise with blood flow restriction (13, 14). 453 
Nonetheless, the phosphorylation status of these proteins as well as 4E-BP1 and eEF2 454 
were unchanged 3 h post-exercise in the current study. While our study design was 455 
somewhat limited by only having the single post-exercise biopsy (9), this sampling 456 
time-point was specifically chosen based on previous studies showing significant, and 457 
in some cases maximal, increases in PGC-1α mRNA expression in response to an 458 
exercise challenge (5, 21, 24, 28). Accordingly, Ozaki et al.,(25) investigated molecular 459 
effects of walking exercise with BFR on mTOR and downstream targets and although 460 
the walking exercise with BFR was performed with higher intensity (55% of VO2peak) 461 
compared to our protocol, it was not found any significant modification to mTOR 462 
signaling. As in our study, probably the biopsy time point was the cause of absence of 463 
significant mTOR and downstream targets difference. Thus, future studies investigating 464 
endurance exercise undertaken with BFR-EE should include a time-course of signaling 465 
responses in order to determine the optimal ‘window’ for muscle sampling in 466 
subsequent investigations. MuRF-1 mRNA expression increased post endurance 467 
exercise which resulted in a higher expression above endurance exercise with BFR and 468 
resistance exercise. MuRF-1 mediates the ubiquitin proteasome system by ‘labelling’ 469 
cleaved myofibril segments for degradation (31). It is unclear whether this increase in 470 
expression with high intensity endurance exercise represents general tissue remodeling, 471 
particularly considering our participants were untrained and the unaccustomed 472 
contractile stimulus, or a greater induction of protein degradation.  473 
 474 
In summary, this is the first study to investigate the molecular mechanisms mediating 475 
muscle adaptation responses to low intensity endurance cycling exercise with blood 476 
flow restriction. The attenuated expression of all four PGC-1α isoforms when endurance 477 
exercise is performed with blood flow restriction suggests this type of exercise is unable 478 
to induce the appropriate metabolic perturbation capable of activating the cell signaling 479 
machinery responsible for mitochondrial biogenesis and angiogenesis responses with 480 
moderate-to-high intensity endurance exercise. Longer training programs incorporating 481 
endurance exercise with BFR that correlate measurements of these molecular markers 482 
with functional adaptation responses such as changes in VO2peak and cycle time to 483 
fatigue will yield important information to the efficacy of this training method to 484 
enhance training adaptation and subsequently improve health outcomes in populations 485 
that may be unable to perform, prolonged exercise.  486 
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Figure 1. (A) Total Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-632 
1α), (B) Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α1), (C) 633 
Peroxisome proliferator-activated receptor-γ coactivator 1α2 (PGC-1α2), (D) 634 
Peroxisome proliferator-activated receptor-γ coactivator 1α3 (PGC-1α3) and (E) 635 
Peroxisome proliferator-activated receptor-γ coactivator 1α4 (PGC-1α4) mRNA 636 
abundance at rest and 3 h  post-exercise recovery following  endurance exercise (EE), 637 
resistance exercise (RE) or low-intensity associated with blood flow restriction (BFR-638 
EE). Values are expressed relative to GAPDH and presented in arbitrary units (mean ± 639 
SD, n=9). a= Significant different from Rest (P≤ 0.05); b= Significant different from 640 
HI-RT (P≤ 0.05); c= Significant different from BFR-EE (P≤ 0.05).   641 
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Figure 2. (A) Vascular endothelial growth factor (VEGF), (B) Cytochrome c oxidase 657 
subunit 4 isoform 1 (COXIV) and (C) hypoxia-inducible factor-1 alpha (HIF-1α) 658 
mRNA abundance at rest and 3 h  post-exercise recovery following  endurance exercise 659 
(EE), resistance exercise (RE) or low-intensity associated with blood flow restriction 660 
(BFR-EE). Values are expressed relative to GAPDH and presented in arbitrary units 661 
(mean ± SD, n=9). a= Significant different from Rest (P≤ 0.05); b= Significant different 662 
from HI-RT (P≤ 0.05); c= Significant different from BFR-EE (P≤ 0.05).  663 
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Figure 3. (A) Interleukin 6 (IL-6), (B) Insulin-like growth factor 1(IGF-1), (C) Muscle 682 
RING finger 1 (MURF1) and (D) Myostatin mRNA abundance at rest and 3 h post-683 
exercise recovery following endurance exercise (EE), resistance exercise (RE) or low-684 
intensity associated with blood flow restriction (BFR-EE). Values are expressed relative 685 
to GAPDH and presented in arbitrary units (mean ± SD, n=9). a= Significant different 686 
from Rest (P≤ 0.05); b= Significant different from HI-RT (P≤ 0.05); c= Significant 687 
different from BFR-EE (P≤ 0.05).    688 
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 700 
Figure 4. (A) Mechanistic target of rapamycin (mTOR)Ser2448 (B) p70S6KThr389 (C) 701 
eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1)Thr37/46 eukaryotic 702 
elongation factor 2 (eEF2)Thr56 phosphorylation in skeletal  muscle at rest and after 3 h  703 
post-exercise recovery following endurance exercise (EE), resistance exercise (RE) or 704 
low-intensity associated with blood flow restriction (BFR-EE). Values are normalized 705 
to total protein loaded determined by stain free technology in arbitrary units (mean ± 706 
SD, n=9).  707 
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Figure 5. (A) Adenosine Monophosphate-Activated Protein (AMPK)Thr172 and (B) 719 
p53Ser15 phosphorylation in skeletal muscle at rest and after 3 h post-exercise recovery 720 
following endurance exercise (EE), resistance exercise (RE) or low-intensity associated 721 
with blood flow restriction (BFR-EE). Values are normalized to total protein loaded 722 
determined by stain free technology in arbitrary units (mean ± SD, n=9). 723 
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